Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Planchard

Showing results (51-60 of 243) with videos related to

Pageof 25
Sort By:
Cancer|December 24, 2003
Uncertain benefit from surgery in patients with lung metastases from breast carcinomaDavid Planchard, Jean-Charles Soria, Stefan Michiels, et al.
Cancer Management and Research|April 5, 2021
Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to EntrectinibFrancesco Facchinetti, Antonin Levy, Samy Ammari, et al.
Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Intervention in gastro-enteropancreatic neuroendocrine tumoursEric Baudin, David Planchard, Jean-Yves Scoazec, et al.
Clinical Lung Cancer|June 7, 2016
A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC StudyDavid Planchard, Takashi Yokoi, Michael J McCleod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokersGiannis Mountzios, David Planchard, Benjamin Besse, et al.
Expert Review of Anticancer Therapy|February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside reviewJohn V Heymach, Sanjay Popat, Egbert F Smit, et al.
European Journal of Endocrinology|November 12, 2014
GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETsThierry de Baere, Frederic Deschamps, Lambros Tselikas, et al.
Plos One|October 11, 2018
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancerAntoine Schernberg, Laura Mezquita, Angela Boros, et al.
The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.
Pageof 25

Showing results (51-60 of 243) with videos related to

Sort By:
Pageof 25
Cancer|December 24, 2003
Uncertain benefit from surgery in patients with lung metastases from breast carcinomaDavid Planchard, Jean-Charles Soria, Stefan Michiels, et al.
Cancer Management and Research|April 5, 2021
Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to EntrectinibFrancesco Facchinetti, Antonin Levy, Samy Ammari, et al.
Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Intervention in gastro-enteropancreatic neuroendocrine tumoursEric Baudin, David Planchard, Jean-Yves Scoazec, et al.
Clinical Lung Cancer|June 7, 2016
A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC StudyDavid Planchard, Takashi Yokoi, Michael J McCleod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokersGiannis Mountzios, David Planchard, Benjamin Besse, et al.
Expert Review of Anticancer Therapy|February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside reviewJohn V Heymach, Sanjay Popat, Egbert F Smit, et al.
European Journal of Endocrinology|November 12, 2014
GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETsThierry de Baere, Frederic Deschamps, Lambros Tselikas, et al.
Plos One|October 11, 2018
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancerAntoine Schernberg, Laura Mezquita, Angela Boros, et al.
The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.
Pageof 25